Haplogen, founded 2010 is a Vienna based, privately owned biotechnology company. Based on a novel mechanism Haplogen develops proprietary small molecule therapeutic compounds for the treatment of diseases that lead to adipositas and obesity.
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. We have leveraged our expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.
Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries.
We are a global healthcare company with a history of more than 125 years, dedicated to improving patients' lives. Our mission is to discover, develop and deliver products and services that help people and animals around the world live healthier lives.
Established in 2007, Lexogen is a leading company in transcriptomics, next-generation sequencing, and RNA analysis. The mission of the Lexogen team is to empower their customers with innovative top quality RNA analysis solutions and support, in order to improve health and well-being for everyone and our planet. Lexogen is the leader in 3’ RNA sequencing, a technology proven for its efficiency, its robustness, and its sensitivity.
Sanochemia is a pharmaceutical niche player centered in the heart of Europe (Neufeld, Austria) with a proven track-record in the development and GMP compliant production of human pharmaceuticals, diagnostics and API´s. By developing, manufacturing and marketing pharmaceutical specialities Sanochemia contributes to human health since over 30 years.